Kyowa Kirin Co., Ltd. (KYKOF)
15.71
0.00 (0.00%)
USD |
OTCM |
Feb 20, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 8.224B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 11.46% |
| Valuation | |
| PE Ratio | 18.50 |
| PE Ratio (Forward) | |
| PS Ratio | 2.477 |
| Price to Book Value | 1.443 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.2278 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.00 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 63.59% |
Profile
| Kyowa Kirin Co., Ltd. engages in the manufacture and sale of medical and pharmaceutical products. It handles the research, development, production, and sale of in vitro diagnostic reagents and ethical drugs concerning renal anemia, leukemia, cancer, allergies, and hypertension. It also produces and sells medical and industrial raw materials such as amino acids, nucleic acid-related compounds, and healthcare products. The company was founded by Benzaburo Kato on July 1, 1949 and is headquartered in Tokyo, Japan. |
| URL | https://www.kyowakirin.co.jp/index.html |
| Investor Relations URL | N/A |
| HQ State/Province | Tokyo |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Apr. 30, 2026 (est.) |
| Last Earnings Release | Feb. 09, 2026 |
| Next Ex-Dividend Date | Jun. 30, 2026 |
| Last Ex-Dividend Date | Dec. 31, 2025 |
Profile
| Kyowa Kirin Co., Ltd. engages in the manufacture and sale of medical and pharmaceutical products. It handles the research, development, production, and sale of in vitro diagnostic reagents and ethical drugs concerning renal anemia, leukemia, cancer, allergies, and hypertension. It also produces and sells medical and industrial raw materials such as amino acids, nucleic acid-related compounds, and healthcare products. The company was founded by Benzaburo Kato on July 1, 1949 and is headquartered in Tokyo, Japan. |
| URL | https://www.kyowakirin.co.jp/index.html |
| Investor Relations URL | N/A |
| HQ State/Province | Tokyo |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Apr. 30, 2026 (est.) |
| Last Earnings Release | Feb. 09, 2026 |
| Next Ex-Dividend Date | Jun. 30, 2026 |
| Last Ex-Dividend Date | Dec. 31, 2025 |